Diabetes in adults quality standard
This NICE quality standard defines clinical best practice within this topic area. It provides specific, concise quality statements, measures and audience descriptors to provide patients and the public, health and social care professionals, commissioners and service providers with definitions of high-quality care – Full PDF (NICE)
Artificial pancreas promise for night-time hypos
Research funded by Diabetes UK, and supported by the Juvenile Diabetes Resarch Foundation (JDRF), has for the first time successfully demonstrated the potential of an ‘artificial pancreas’ in preventing night-time hypoglycaemia in adults with Type 1 diabetes (Diabetes UK)
The utility of hemoglobin A1c at diagnosis for prediction of future glycemic control in children with type 1 diabetes
In children with newly diagnosed diabetes, A1cs at diagnosis and one year post diagnosis are related to subsequent glycemic control. Children with high A1cs particularly at one year post diagnosis may benefit from targeted intensification of resources (Diabetes Research and Clinical Practice)
The Cost-Effectiveness of Three Screening Alternatives for People with Diabetes with No or Early Diabetic Retinopathy
Annual eye evaluations are costly and add little benefit compared with either plausible alternative. More research on the ability of telemedicine to detect other eye conditions is needed to determine whether it is more cost-effective than biennial eye evaluation (Health Services Research)
BYDUREON™ Recommended for Approval in Europe
BYDUREON Would Be First Once-Weekly Treatment for Adults with Type 2 Diabetes (Lilly)
Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes.
A 6-week treatment with ezetimibe and simvastatin, compared to simvastatin alone, positively influences lipoprotein profile both at fasting and postprandially in type 2 diabetic patients by favouring the production of cholesterol-poor chylomicrons and VLDL particles that have less atherogenic potential (PubMed)
Amylin, Alkermes Shares Jump as EU Regulators Recommend Diabetes Drug
San Diego-based Amylin, along with Lilly and Waltham, MA-based Alkermes, said that their once-weekly version of exenatide (Bydureon) received a recommendation for approval in Europe (Xconomy San Diego)
Mobile phone intervention improves glycemic control in type 2 diabetes patients
The results of the analysis indicate that the innovative use of mobile phone interventions in the self-management of diabetes significantly improve glycemic control especially in individuals with type 2 diabetes (Diabetes Pro)
Glycosmedia is also available as an App: